Stellaard F - Search Results

1

Influence of Chitosan Treatment on Surrogate Serum Markers of Cholesterol Metabolism in Obese Subjects.

Lütjohann D, Marinova M, Wolter K, Willinek W, Bitterlich N, Coenen M, Coch C, Stellaard F. Lütjohann D, et al. Among authors: stellaard f. Nutrients. 2018 Jan 11;10(1):72. doi: 10.3390/nu10010072. Nutrients. 2018. PMID: 29324705 Free PMC article. Clinical Trial.

2

Fractional cholesterol absorption measurements in humans: determinants of the blood-based dual stable isotope tracer technique.

Stellaard F, Lütjohann D. Stellaard F, et al. J Clin Lipidol. 2015 Jan-Feb;9(1):14-25. doi: 10.1016/j.jacl.2014.11.002. Epub 2014 Nov 13. J Clin Lipidol. 2015. PMID: 25670356 Review.

3

The value of surrogate markers to monitor cholesterol absorption, synthesis and bioconversion to bile acids under lipid lowering therapies.

Stellaard F, von Bergmann K, Sudhop T, Lütjohann D. Stellaard F, et al. J Steroid Biochem Mol Biol. 2017 May;169:111-122. doi: 10.1016/j.jsbmb.2016.03.030. Epub 2016 Apr 6. J Steroid Biochem Mol Biol. 2017. PMID: 27060336

4

The Interpretation of Cholesterol Balance Derived Synthesis Data and Surrogate Noncholesterol Plasma Markers for Cholesterol Synthesis under Lipid Lowering Therapies.

Stellaard F, Lütjohann D. Stellaard F, et al. Cholesterol. 2017;2017:5046294. doi: 10.1155/2017/5046294. Epub 2017 Feb 22. Cholesterol. 2017. PMID: 28321334 Free PMC article. Review.

5

Cholesterol Absorption and Synthesis in Vegetarians and Omnivores.

Lütjohann D, Meyer S, von Bergmann K, Stellaard F. Lütjohann D, et al. Among authors: stellaard f. Mol Nutr Food Res. 2018 Mar;62(6):e1700689. doi: 10.1002/mnfr.201700689. Epub 2018 Feb 23. Mol Nutr Food Res. 2018. PMID: 29427539

6

The emerging concept of "individualized cholesterol-lowering therapy": A change in paradigm.

Lütjohann D, Stellaard F, Mulder MT, Sijbrands EJG, Weingärtner O. Lütjohann D, et al. Among authors: stellaard f. Pharmacol Ther. 2019 Jul;199:111-116. doi: 10.1016/j.pharmthera.2019.03.004. Epub 2019 Mar 12. Pharmacol Ther. 2019. PMID: 30877023 Review.

7

Interaction of chylomicron remnants and VLDLs during ultracentrifuge separation based on the Svedberg flotation rate.

Stellaard F, Lütjohann D. Stellaard F, et al. J Intern Med. 2020 Jan;287(1):117. doi: 10.1111/joim.13000. Epub 2019 Nov 10. J Intern Med. 2020. PMID: 31709626 Free article. No abstract available.

8

Levels of 7alpha-hydroxycholesterol and/or 7alpha-hydroxy-4-cholest-3-one are the optimal biochemical markers for the evaluation of treatment of cerebrotendinous xanthomatosis.

Lütjohann D, Stellaard F, Björkhem I. Lütjohann D, et al. Among authors: stellaard f. J Neurol. 2020 Feb;267(2):572-573. doi: 10.1007/s00415-019-09650-0. Epub 2019 Nov 28. J Neurol. 2020. PMID: 31781930 No abstract available.

9

Serum 4β-hydroxycholesterol increases during fluconazole treatment.

Lütjohann D, Stellaard F, Kerksiek A, Lötsch J, Oertel BG. Lütjohann D, et al. Among authors: stellaard f. Eur J Clin Pharmacol. 2021 May;77(5):659-669. doi: 10.1007/s00228-020-03041-5. Epub 2020 Nov 17. Eur J Clin Pharmacol. 2021. PMID: 33201347 Free PMC article. Clinical Trial.

10

Anti-PCSK 9 antibodies increase the ratios of the brain-specific oxysterol 24S-hydroxycholesterol to cholesterol and to 27-hydroxycholesterol in the serum.

Lütjohann D, Stellaard F, Bölükbasi B, Kerksiek A, Parhofer KG, Laufs U. Lütjohann D, et al. Among authors: stellaard f. Br J Clin Pharmacol. 2021 Nov;87(11):4252-4261. doi: 10.1111/bcp.14841. Epub 2021 May 4. Br J Clin Pharmacol. 2021. PMID: 33792095 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters